Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Expectation in ADHD and SUD
NCT02477280Phase 4Completed
- Sponsor
- Region Västmanland
- Start
- Sep 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Region Västmanland. Started Sep 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02477280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477280.